Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PESETA Trial: Progesterone Added to EDP-M Chemotherapy in Advanced Adrenocortical Carcinoma
2020-004530-38Phase 2Active
- Sponsor
- ASST Spedali Civili di Brescia
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of megestrol in adrenal cancer (ACC), sponsored by ASST Spedali Civili di Brescia. Primary endpoint: Evaluation of efficacy. Started Jan 2022; status: active.
02
Drugs
megestrol
03
Conditions
adrenal cancer (ACC)
Beyond the preview
Go deeper on 2020-004530-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004530-38.